Podrobno

Fibrosis-related microRNAs in Crohn’s disease with fibrostenosis and inflammatory stenosis
ID Jerala, Miha (Avtor), ID Remic, Tinkara (Avtor), ID Hauptman, Nina (Avtor), ID Zidar, Nina (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,36 MB)
MD5: D42F6BE8CFA25B125A20AD8246B0DD0A
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1422-0067/25/16/8826 Povezava se odpre v novem oknu

Izvleček
Crohn’s disease (CD) is frequently complicated by strictures that can be either inflammatory or fibrostenotic. This distinction is important for deciding the best treatment course, but it can be difficult to determine clinically, sometimes even by advanced imaging techniques. We performed miRNA PCR panel screening on pooled samples of ileum with CD fibrostenosis or inflammatory stenosis. Eight miRNAs with profibrotic (miR-93-5p, miR-376c-3p and miR-424-5p), or fibroprotective (miR-133a-3p, miR-133b, miR-193a-5p, miR-335-5p and miR-378a-3p) functions described in the literature were selected for validation on 20 samples each of CD with fibrostenosis or inflammatory stenosis, with a separate sampling of the submucosa and subserosa. The results showed significant differences between the groups in subserosal samples, with upregulation of profibrotic miRNAs and downregulation of fibroprotective miRNAs in fibrostenosis compared to inflammatory stenosis. Only miR-424-5p showed a significant difference in the submucosa. There were significant differences in miRNA expression between subserosa and submucosa. Our results provide further evidence that the major differences between fibrostenosis and inflammatory stenosis are located in the subserosa, which is inaccessible to endoscopic sampling, highlighting the need for cross-sectional imaging or serological markers. We identify several miRNAs previously not connected to fibrosis in CD, which could potentially serve as biomarkers of fibrostenosis.

Jezik:Angleški jezik
Ključne besede:Crohn’s disease, fibrostenosis, inflammatory stenosis, fibrosis, miRNA
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:11 str.
Številčenje:Vol. 25, iss. 16, art. 8826
PID:20.500.12556/RUL-166788 Povezava se odpre v novem oknu
UDK:616
ISSN pri članku:1422-0067
DOI:10.3390/ijms25168826 Povezava se odpre v novem oknu
COBISS.SI-ID:205623299 Povezava se odpre v novem oknu
Datum objave v RUL:24.01.2025
Število ogledov:530
Število prenosov:83
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:International journal of molecular sciences
Skrajšan naslov:Int. j. mol. sci.
Založnik:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:Crohnova bolezen, fibrostenoza, vnetna stenoza, fibroza, miRNA

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0054
Naslov:Patologija in molekularna genetika

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj